Topics

Glioblastoma | Treatment | Clinical trials | Resection extent

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Resection extent

Doron O, Wong T, Ablyazova F, Singha S, Cavallaro J, Ben-Shalom N, D'Amico RS, Harshan M, McKeown A, Zlochower A, Langer DJ, Boockvar JA.
Results from a first-in-human phase i safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma.
J Neurooncol. 2024 Apr 26. doi: 10.1007/s11060-024-04647-w. PMID: 38664311. Interventional study. ˍ

Gerritsen JKW, Young JS, Chang SM, Krieg SM, Jungk C, van den Bent MJ, Satoer DD, Ille S, Schucht P, Nahed BV, Broekman MLD, Berger M, De Vleeschouwer S, Vincent AJPE.
SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201).
BMJ Open. 2024 Apr 29;14(4):e082274. doi: 10.1136/bmjopen-2023-082274. PMID: 38684246. Interventional study protocol. ˍ

Sonoda Y, Sekino Y, Mizusawa J, Shibahara I, Sasaki K, Sekita T, Ichikawa M, Igaki H, Kinoshita M, Shibahara J, Ichimura K, Arakawa Y, Fukuda H, Narita Y.
AB012. A phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery (FLAIR) hyperintensity lesion on magnetic resonance image for newly diagnosed supratentorial glioblastoma (JCOG2209).
Chin Clin Oncol. 2024 Aug 30;13(Suppl 1):AB012. doi: 10.21037/cco-24-ab012. PMID: 39295330. Interventional study. ˍ

Schneider M, Potthoff AL, Ahmadipour Y, Borger V, Clusmann H, Combs SE, Czabanka M, Dührsen L, Etminan N, Freiman TM, Gerlach R, Gessler F, Giordano FA, Gkika E, Goldbrunner R, Güresir E, Hamou H, Hau P, Ille S, Jägersberg M, Keric N, Khaleghi-Ghadiri M, König R, Konczalla J, Krenzlin H, Krieg S, McLean AL, Layer JP, Lehmberg J, Malinova V, Meyer B, Meyer HS, Miller D, Müller O, Musahl C, Pregler BEF, Rashidi A, Ringel F, Roder C, Rössler K, Rohde V, Sandalcioglu IE, Schäfer N, Schaub C, Schmidt NO, Schubert GA, Seidel C, Seliger C, Senft C, Shawarba J, Steinbach J, Stöcklein V, Stummer W, Sure U, Tabatabai G, Tatagiba M, Thon N, Timmer M, Wach J, Wagner A, Wirtz CR, Zeiler K, Zeyen T, Schuss P, Surges R, Fuhrmann C, Paech D, Schmid M, Borck Y, Pietsch T, Struck R, Radbruch A, Helmstaedter C, Németh R, Herrlinger U, Vatter H.
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma.
BMC Cancer. 2025 Feb 20;25(1):306. doi: 10.1186/s12885-025-13682-3. PMID: 39979825. Interventional study protocol. ˍ